Related Experiment Video
Updated: May 9, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
AIDS and the pancreas in the HAART era: a cross sectional study
Alexandre G Barbosa1, Ethel Z Chehter, Marcelo R Bacci
1Department of General Practice, Faculdade de Medicina do ABC, Santo André, Brazil. mrbacci@yahoo.com.
Insights
Highly Active Antiretroviral Therapy (HAART) use in AIDS patients shows lighter pancreatic abnormalities. Autopsies revealed increased atrophy and apoptosis, but no direct lesions from HAART, suggesting therapy
Area of Science:
- Pathology
- Virology
- Immunology
Background:
- Acquired Immunodeficiency Syndrome (AIDS) patients on Highly Active Antiretroviral Therapy (HAART) exhibit distinct pancreatic morphological patterns.
- Understanding these patterns is crucial for managing long-term complications in HIV-infected individuals.
Purpose of the Study:
- To identify and characterize the main morphological patterns of the pancreas in AIDS patients receiving HAART.
- To compare pancreatic morphology between HAART users and non-users.
Main Methods:
- Cross-sectional study conducted in 2010, comparing 2010 autopsies of HAART users (2006-2009) with 109 AIDS patients from 1995 (pre-HAART).
- Inclusion criteria: patients >18 years old, died of AIDS, and underwent autopsy.
- Autopsies performed at the Death Verification Service of São Paulo.
Main Results:
- HAART group showed milder pancreatic abnormalities compared to the non-HAART group.
- Histology in the HAART group revealed a higher percentage of acinar cell atrophy and reduction of zymogen granules, with fewer 'dysplasia-like' features.
- The exocrine pancreas in HAART patients was characterized by significant atrophy, reduced zymogen granules, and increased apoptosis, indicating degeneration and potentially lower malnutrition.
Conclusions:
- Increased number and volume of islets of Langerhans with nuclear dysplasia were observed in the HAART group.
- Antiviral therapy and longer survival led to increased pancreatic atrophy and enzyme reduction, raising apoptosis and altering pancreatic islets.
- No direct histopathological pancreatic lesions secondary to antiretroviral therapy were identified.
Backgrounds:
The aim of this study is identify the main morphological patterns of the pancreas in AIDS patients in use of Higly Active Antiretorviral Therapy (HAART).
Methods:
We conducted a cross sectional study in the year of 2010. The inclusion criteria were patients older than 18 years who died of AIDS with the use of HAART (2006-2009) and underwent to autopsy . They were compared with a group of 109 patients who died of AIDS in 1995 before the HAART therapy. All the autopsies were made in the Death Verification Service of São Paulo.
Results:
The HAART group presented pancreas abnormalities lighter than no HAART users. In the HAART group, histology shows: reduction of zymogen granules in the acinar cells (ZG) higher percentage of cases, "dysplasia-like" presents lower and pancreatic acinar atrophy, presents higher percentage of cases compared to no HAART group. The exocrine pancreas in treated patients was distinguished by the high level of atrophy, sharp reduction of zymogen granules and high level of apoptosis, reflecting degeneration and lower level of protein-caloric malnutrition.
Conclusions:
The islets of Langerhans in HAART group were increased in number and volume and with high level of nuclear dysplasia. The antiviral therapy and a longer survival resulted in a higher atrophy and reduction of enzymes, increasing the apoptosis and generated important changes in the pancreatic islets, probably resulting in clinical laboratory repercussion.We found no evidence of pancreatic histopathological lesions secondary to antiretroviral therapy.
Related Concept Videos
Retrovirus Life Cycles
Sexually Transmitted Infections
Chronic Pancreatitis II: Collaborative Care
Assessment:
Chronic Pancreatitis I: Introduction

